During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released Friday by the Centers for Disease Control and Prevention. A third dose was more effective than a second dose but less effective over time, the study found. 

In a separate study reported Friday, adverse reactions were less frequent after a third dose than a second dose in adults who received the same COVID-19 vaccine for all their doses. 
 

Related News Articles

Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Headline
The National Institutes of Health Oct. 10 released results of a study that found that infection from COVID-19 in the first wave of the pandemic appeared to…